Dr. Renee Aketch Debose, MD

Dr. Debose practices at Sacramento Midtown Endoscopy Center in Sacramento, California.

Dr. Debose's NPI, 1780772897, was assigned on October 11, 2006. Dr. Debose graduated from Ohio State College of Medicine in 2002. Dr. Debose holds California license A91369.

Dr. Debose's primary practice is Sacramento Midtown Endoscopy Center, at 3941 J Street, Suite 460, Sacramento, CA 95819. The practice phone is (916) 733-6940.

Dr. Debose's primary practice is Sacramento Midtown Endoscopy Center in Sacramento, California. Dr. Debose is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Debose to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Debose practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Debose's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Debose is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Debose's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, hepatitis c and intestinal diverticulosis among the conditions Dr. Debose treats.

CMS data shows 637 Medicare services from Dr. Debose across 14 procedure codes in 2024, for 368 Medicare patients. Medicare paid $75,970 for them.

CMS counts 368 Medicare patients who saw Dr. Debose in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Debose's median patient age at 63, with 63% women.

In 2024, Dr. Debose wrote 1,030 Medicare Part D claims for 291 patients. 71% of them were for generic drugs. CMS names the drug for 849 of them, across 21 drugs with 11 or more claims each, at $463,082 in total drug cost. In 2023, CMS named 1,009 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Debose for performance year 2024, reported through an alternative payment model (APM). Dr. Debose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Debose as offering telehealth. CMS counts 98 procedures of colonoscopy by Dr. Debose, more than 79% of the clinicians it reports for that procedure.

CMS Open Payments shows 348 general payments to Dr. Debose from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,912.

Dr. Debose graduated from Ohio State College of Medicine in 2002.

Dr. Debose is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.